Acadia Pharmaceuticals is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world.
The Associate Director in the Early Stage Drug Product Development organization at Acadia is responsible for the development of pharmaceutical formulations primarily intended for early-stage clinical trials and preclinical animal studies. This role also supports drug discovery teams by assisting in the selection of optimal drug candidates through detailed physicochemical characterization and assessment of compound properties.
Acadia Pharmaceuticals is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world.
Akero Therapeutics